Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-049016)

Filing Details

Accession Number:: 0001209191-23-049016
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-09-11 19:13:26
Reporting Period:: 2023-09-11

Accepted Time:: 2023-09-11 19:13:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1427925	Acelrx Pharmaceuticals Inc	ACRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1700225	J. Vincent Angotti	C/O Acelrx Pharmaceuticals, Inc. 1850 Gateway Drive, Suite 175 San Mateo CA 94404	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-09-11	10,000	$0.80	91,805	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Balance includes non-reportable acquisitions of 7,969 and 10,000 shares of Common Stock through the Company's Employee Stock Purchase Plan on February 28, 2023 and August 31, 2023, respectively.